Ha seleccionado la visión en Inglés
Descriptor en español: |
Acrecentamiento Dependiente de Anticuerpo
| ||||
Descriptor en inglés: | Antibody-Dependent Enhancement | ||||
Descriptor en portugués: | Anticorpos Facilitadores | ||||
Descriptor en francés: | Facilitation dépendante des anticorps | ||||
Término(s) alternativo(s): |
Antibody Dependent Enhancement Antibody-Dependent Enhancements Enhancement, Antibody-Dependent |
||||
Código(s) jeráquico(s): |
G06.920.095 G12.113 |
||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D019067 | ||||
Nota de alcance: | Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors (RECEPTORS, FC) or by complement receptors (RECEPTORS, COMPLEMENT). Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors. |
||||
Nota de indización: | enhancement of viral infectivity: read MeSH definition |
||||
Calificadores permitidos: |
DE drug effects GE genetics IM immunology PH physiology RE radiation effects |
||||
Nota Pública de MeSH: | 96 |
||||
Nota de historia: | 96 |
||||
Identificador de DeCS: | 32854 | ||||
ID del Descriptor: | D019067 | ||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||
Fecha de establecimiento: | 01/01/1996 | ||||
Fecha de entrada: | 26/05/1995 | ||||
Fecha de revisión: | 09/02/2016 |
-
-
PHENOMENA AND PROCESSES
Microbiological Phenomena [G06]Microbiological Phenomena -
PHENOMENA AND PROCESSES
Immune System Phenomena [G12]Immune System Phenomena
|
Antibody-Dependent Enhancement
- Concepto preferido
UI del concepto |
M0028464 |
Nota de alcance | Enhancement of viral infectivity caused by non-neutralizing antibodies. There are at least two mechanisms known to account for this: mediation by Fc receptors (RECEPTORS, FC) or by complement receptors (RECEPTORS, COMPLEMENT). Either the virus is complexed with antiviral IMMUNOGLOBULIN G and binds to Fc receptors, or virus is coated with antiviral IMMUNOGLOBULIN M and binds to complement receptors. |
Término preferido | Antibody-Dependent Enhancement |
Término(s) alternativo(s) |
Antibody Dependent Enhancement Antibody-Dependent Enhancements Enhancement, Antibody-Dependent |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta